Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization-Reference-Cited by-同舟云学术

Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization

Published:2023-07-03 Issue:13 Volume:15 Page:6011-6030
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Nyati Shyam¹²,Young Grant¹,Speers Corey¹³,Nyati Mukesh K.¹,Rehemtulla Alnawaz¹

Affiliation:

1. Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA

2. Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA

3. Department of Radiation Oncology, UH Seidman Cancer Center, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference67 articles.

1. The EGF receptor family as targets for cancer therapy.;Baselga;Oncogene,2000

2. EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.;Lawrence;Pharmacol Ther,2015

3. Integration of EGFR inhibitors with radiochemotherapy.;Lawrence;Nat Rev Cancer,2006

4. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation.;Wang;EMBO Rep,2005

5. Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases.;Schlessinger;Mol Cells,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mosaic variegated aneuploidy in development, ageing and cancer;Nature Reviews Genetics;2024-08-21

2. Exploration of biomarkers for nursing physical examination early screening of multiple tumors;Medicine;2024-08-16

3. Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies;Scientific Reports;2024-02-23